Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN111253395A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111253395A details a novel FeCl3-catalyzed route to NPDOs, offering improved atom economy and cost reduction in pharmaceutical intermediate manufacturing compared to traditional methods.